The Prognosis of Myeloma and Macroglobulinemia
One of the most interesting problems in modern mediane is whether survival of patients with solitary solid tumors (cancers) and with systemic diseases, such as leukemia, lymphoma, and plasmocytoma, is really prolonged by modern treatment with cytostatic drugs. The number of solid tumors that are healed with such treatment is very low, and it must still be acknowledged that we have much to learn and hope for in this fleld. Regarding systemic diseases, the goal should be what has been called “eradication of the last cell”. Hodgkin’s disease, when treated with irradiation, in favorable cases sometimes combined with cytostatic drugs, is definitely healed. Non-Hodgkin lymphoma is much more difficult to treat with lasting success, if we except Burkitt’s lymphoma that has a some-what special position.
KeywordsMultiple Myeloma Acute Leukemia Cytostatic Drug Cold Agglutinin Chronic Leukemia
Unable to display preview. Download preview PDF.